Search

everythinglearnresearchcommunity

for

Search:↓

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Long-COVID has diverse, long-term health impacts, especially in young people.

Various treatments exist for hair loss, but no definitive solution.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Skin conditions can cause significant psychological distress, so addressing mental health is crucial for improving quality of life.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Clomipramine alone does not reduce overgrooming in cats with psychogenic alopecia.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

30% supramolecular salicylic acid is safe and effective for treating mild to moderate facial acne.

The document is a detailed medical reference on skin and genetic disorders.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The model and estimator can predict drug exposure in kidney transplant patients well.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

Some botanical products may help increase hair growth in people with alopecia, but more research is needed.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Melatonin directly affects mouse hair follicles and may influence hair growth.